Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Kensey Nash Corporation Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   41
ISBN Number   not applicable
Product Code   GMD689
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Kensey Nash Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1.1 List Of Tables
  • 1.2 List of Figures
  • 2 Company Overview
  • 2.1 Key Information
  • 2.2 Industry Outlook - Cardiovascular Devices
  • 2.3 Industry Outlook - Orthopedic Devices
  • 3 Major Products and Services
  • 3.1 Overview
  • 4 Competitors
  • 5 Key Employees
  • 6 Locations And Subsidiaries
  • 6.1 Head Office
  • 7 Recent Developments
  • 7.1 Financial Announcements
    • 7.1.1 Jun 23, 2008: Kensey Provides Q4 Fiscal 2008 Guidance
    • 7.1.2 Apr 29, 2008: Kensey Declares Q3 Fiscal 2008 Results
    • 7.1.3 Apr 10, 2008: Kensey To Declare Q3 Fiscal 2008 Results
    • 7.1.4 Jan 25, 2008: Kensey Declares Q2 Fiscal 2008 Results
    • 7.1.5 Jan 04, 2008: Kensey To Declare Q2 Fiscal 2008 Results
    • 7.1.6 Oct 19, 2007: Kensey Declares Q1 Fiscal 2008 Results
    • 7.1.7 Aug 20, 2007: Kensey Declares Q4 Fiscal 2007 Results
    • 7.1.8 Apr 23, 2007: Kensey Declares Q3 Fiscal 2007 Results
    • 7.1.9 Jan 26, 2007: Kensey Declares Q2 Fiscal 2007 Results
  • 7.2 Product News
    • 7.2.1 Feb 20, 2008: Kensey Nash Receives FDA 510(k) Clearance For New Safe-Cross Vessel Wall Detection Technology
    • 7.2.2 Apr 10, 2007: Kensey Nash Receives Expanded CE Mark Approval For TriActiv ProGuard Embolic Protection System In Carotid Anatomy
    • 7.2.3 Nov 15, 2006: Kensey Nash Announces Commencement Of Carotid Pivotal Trial For TriActiv ProGuard System
  • 7.3 Product Approvals
    • 7.3.1 Feb 20, 2008: Kensey Nash Receives FDA 510(k) Clearance For New Safe-Cross Vessel Wall Detection Technology
    • 7.3.2 Apr 10, 2007: Kensey Nash Receives Expanded CE Mark Approval For TriActiv ProGuard Embolic Protection System In Carotid Anatomy
  • 7.4 Clinical Trials
    • 7.4.1 Nov 15, 2006: Kensey Nash Announces Commencement Of Carotid Pivotal Trial For TriActiv ProGuard System
  • 8 Kensey Nash Corporation Pipeline Products
  • 8.1 Kensey Nash Corporation Product Pipeline Analysis
    • 8.1.1 Kensey Nash Corporation Pipeline Products By Equipment Type
    • 8.1.2 Kensey Nash Corporation Pipeline Products By Development Stage
    • 8.1.3 Kensey Nash Corporation Pipeline Products By Therapy Area
    • 8.1.4 Kensey Nash Corporation Pipeline Products By Clinical Trials
    • 8.1.5 Kensey Nash Corporation Pipeline Products By News Summary
  • 8.2 TriActiv ProGuard system
    • 8.2.1 Product Description
    • 8.2.2 Product Status
    • 8.2.3 Clinical Trials
    • 8.2.4 Product Milestone
  • 8.3 Annulus Repair Closure Device and Delivery System
    • 8.3.1 Product Description
    • 8.3.2 Product Status
  • 8.4 Porous Resorbable Interbody Spacer
    • 8.4.1 Product Description
    • 8.4.2 Product Status
  • 8.5 Safe-Cross RF CTO System
    • 8.5.1 Product Description
    • 8.5.2 Product Status
    • 8.5.3 Product Milestone
  • 8.6 ThromCat Thrombectomy Catheter System- coronary application
    • 8.6.1 Product Description
    • 8.6.2 Product Status
    • 8.6.3 Clinical Trials
  • 8.7 Synthetic Vascular Graft
    • 8.7.1 Product Description
    • 8.7.2 Product Status
  • 8.8 Articular Cartilage Regeneration Matrix
    • 8.8.1 Product Description
    • 8.8.2 Product Status
  • 9 Appendix
  • 9.1 Methodology
    • 9.1.1 Coverage
    • 9.1.2 Secondary Research
    • 9.1.3 Primary Research
    • 9.1.4 Expert Panel Validation
  • 9.2 Contact Us
  • 9.3 About Global Markets Direct
  • 9.4 Disclaimer
  • 1 List of Tables
  • Table 1: Kensey Nash Corporation,Key Facts
  • Table 2: Kensey Nash Corporation, Key Employees,
  • Table 3: Kensey Nash Corporation Pipeline Products by Equipment Type
  • Table 4: Kensey Nash Corporation Pipeline Products By Development Stage
  • Table 5: Kensey Nash Corporation Pipeline Products By Therapy Area
  • Table 6: Kensey Nash Corporation Pipeline Products By Clinical Trials
  • Table 7: Kensey Nash Corporation Pipeline Products By News Summaries
  • 1.2 List of Figures
  • Figure 1: Kensey Nash Corporation Pipeline Products By Equipment Type
  • Figure 2: Kensey Nash Corporation Pipeline Products By Equipment Type
  • Figure 3: Kensey Nash Corporation Pipeline Products By Development Stage
  • Figure 4: Global Markets Direct Methodology